Encorafenib, Binimetinib, and Cetuximab in BRAF V600E–Mutated Colorectal Cancer
Kopetz, Scott, Grothey, Axel, Yaeger, Rona, Van Cutsem, Eric, Desai, Jayesh, Yoshino, Takayuki, Wasan, Harpreet, Ciardiello, Fortunato, Loupakis, Fotios, Hong, Yong Sang, Steeghs, Neeltje, Guren, Tormod K, Arkenau, Hendrik-Tobias, Garcia-Alfonso, Pilar, Pfeiffer, Per, Orlov, Sergey, Lonardi, Sara, Elez, Elena, Kim, Tae-Won, Schellens, Jan H.M, Guo, Christina, Krishnan, Asha, Dekervel, Jeroen, Morris, Van, Calvo Ferrandiz, Aitana, Tarpgaard, L.S, Braun, Michael, Gollerkeri, Ashwin, Keir, Christopher, Maharry, Kati, Pickard, Michael, Christy-Bittel, Janna, Anderson, Lisa, Sandor, Victor, Tabernero, Josep
Published in The New England journal of medicine (24.10.2019)
Published in The New England journal of medicine (24.10.2019)
Get full text
Journal Article
First-in-human, open-label, phase 1/2 study of the monoclonal antibody programmed cell death protein-1 (PD-1) inhibitor cetrelimab (JNJ-63723283) in patients with advanced cancers
Felip, Enriqueta, Moreno, Victor, Morgensztern, Daniel, Curigliano, Giuseppe, Rutkowski, Piotr, Trigo, José Manuel, Calvo, Aitana, Kowalski, Dariusz, Cortinovis, Diego, Plummer, Ruth, Maio, Michele, Ascierto, Paolo A., Vladimirov, Vladimir I., Cervantes, Andres, Zudaire, Enrique, Hazra, Anasuya, T’jollyn, Huybrecht, Bandyopadhyay, Nibedita, Greger, James G., Attiyeh, Edward, Xie, Hong, Calvo, Emiliano
Published in Cancer chemotherapy and pharmacology (01.04.2022)
Published in Cancer chemotherapy and pharmacology (01.04.2022)
Get full text
Journal Article
Oral drugs in the treatment of metastatic colorectal cancer
García-Alfonso, Pilar, Muñoz Martín, Andrés Jesús, Ortega Morán, Laura, Soto Alsar, Javier, Torres Pérez-Solero, Gabriela, Blanco Codesido, Montserrat, Calvo Ferrandiz, Pilar Aitana, Grasso Cicala, Silvina
Published in Therapeutic Advances in Medical Oncology (2021)
Published in Therapeutic Advances in Medical Oncology (2021)
Get full text
Book Review
Journal Article
The AGAMENON-SEOM model for prediction of survival in patients with advanced HER2-positive oesophagogastric adenocarcinoma receiving first-line trastuzumab-based therapy
Jimenez-Fonseca, Paula, Foy, Victoria, Raby, Sophie, Carmona-Bayonas, Alberto, Macía-Rivas, Lola, Arrazubi, Virginia, Cacho Lavin, Diego, Hernandez San Gil, Raquel, Custodio, Ana, Cano, Juana María, Fernández Montes, Ana, Mirallas, Oriol, Macias Declara, Ismael, Vidal Tocino, Rosario, Visa, Laura, Limón, María Luisa, Pimentel, Paola, Martínez Lago, Nieves, Sauri, Tamara, Martín Richard, Marta, Mangas, Monserrat, Gil Raga, Mireia, Calvo, Aitana, Reguera, Pablo, Granja, Mónica, Martín Carnicero, Alfonso, Hernández Pérez, Carolina, Cerdá, Paula, Gomez Gonzalez, Lucía, Garcia Navalon, Francisco, Pacheco Barcia, Vilma, Gutierrez Abad, David, Ruiz Martín, Maribel, Weaver, Jamie, Mansoor, Wasat, Gallego, Javier
Published in Therapeutic advances in medical oncology (01.01.2023)
Published in Therapeutic advances in medical oncology (01.01.2023)
Get full text
Journal Article
A phase Ib study evaluating the recommended phase II dose, safety, tolerability, and efficacy of mivavotinib in combination with nivolumab in advanced solid tumors
Juric, Dejan, Barve, Minal, Vaishampayan, Ulka, Roda, Desamparados, Calvo, Aitana, Jañez, Noelia Martinez, Trigo, Jose, Greystoke, Alastair, Harvey, R. Donald, Olszanski, Anthony J., Opyrchal, Mateusz, Spira, Alexander, Thistlethwaite, Fiona, Jiménez, Begoña, Sappal, Jessica Huck, Kannan, Karuppiah, Riley, Jason, Li, Cheryl, Li, Cong, Gregory, Richard C., Miao, Harry, Wang, Shining
Published in Cancer medicine (Malden, MA) (01.03.2024)
Published in Cancer medicine (Malden, MA) (01.03.2024)
Get full text
Journal Article
616 Pharmacokinetics and safety of a subcutaneous formulation of nivolumab (NIVO SC) monotherapy: updated results from the phase 1/2 CheckMate 8KX study
Lonardi, Sara, Ługowska, Iwona, O’Donnell, Anne, Jackson, Christopher, Latten-Jansen, Loes Maria, North, Richard, Salvo, Marcelo Garrido, Santoro, Armando, Chacón, Matías, Li, Linghui, Joseph, Devanand, Gibson, Elizabeth, Bennett, Bryan, Gurm, Balmeet, Ng, Wee-Teck, Donald Harvey, R, Trigo Pérez, José Manuel, Calvo, Aitana
Published in Journal for immunotherapy of cancer (01.11.2023)
Published in Journal for immunotherapy of cancer (01.11.2023)
Get full text
Journal Article
Reagent-free determination of γ-butyrolactone in beverages
Gallart Mateu, Daniel, Aitana Lloret Calvo, Gracia, Garrigues Mateo, Salvador, de la Guardia Cirugeda, Miguel
Published in Microchemical journal (01.05.2024)
Published in Microchemical journal (01.05.2024)
Get full text
Journal Article
Intratumoral nanoplexed poly I:C BO-112 in combination with systemic anti-PD-1 for patients with anti-PD-1-refractory tumors
Márquez-Rodas, Iván, Longo, Federico, Rodriguez-Ruiz, Maria E, Calles, Antonio, Ponce, Santiago, Jove, Maria, Rubio-Viqueira, Belén, Perez-Gracia, Jose Luis, Gómez-Rueda, Ana, López-Tarruella, Sara, Ponz-Sarvise, Mariano, Álvarez, Rosa, Soria-Rivas, Ainara, de Miguel, Enrique, Ramos-Medina, Rocío, Castañon, Eduardo, Gajate, Pablo, Sempere-Ortega, Cayetano, Jiménez-Aguilar, Elisabeth, Aznar, M Angela, Calvo, Aitana, Lopez-Casas, Pedro P, Martín-Algarra, Salvador, Martín, Miguel, Tersago, Dominique, Quintero, Marisol, Melero, Ignacio
Published in Science translational medicine (14.10.2020)
Published in Science translational medicine (14.10.2020)
Get more information
Journal Article
Phase I dose-escalation of trifluridine/tipiracil in combination with oxaliplatin in patients with metastatic colorectal cancer
Argilés, Guillem, André, Thierry, Hollebecque, Antoine, Calvo, Aitana, Dahan, Laetitia, Cervantes, Andrés, Leger, Catherine, Amellal, Nadia, Fougeray, Ronan, Tabernero, Josep
Published in European journal of cancer (1990) (01.05.2019)
Published in European journal of cancer (1990) (01.05.2019)
Get full text
Journal Article
Survival benefit and clinical characteristics of patients with metastatic colorectal cancer (mCRC) receiving pulmonary metastasectomy
Soto Alsar, Javier, Jiménez Rodríguez, Roberto, Bringas Beranek, Marianela, Gutiérrez Alonso, Natalia, Martín Lozano, Rocío, Gonzalez Caraballo, Irene, Pérez Pérez, Sara, González Casaurrán, Guillermo, Muñoz, Andrés, Ortega Morán, Laura, Calvo, Aitana, Torres Pérez-Solero, Gabriela, Martin, Miguel, Simón Adiego, Carlos María, Garcia-Alfonso, Pilar
Published in Journal of clinical oncology (20.01.2024)
Published in Journal of clinical oncology (20.01.2024)
Get full text
Journal Article
Early safety from a phase I, multicenter, open-label clinical trial of talimogene laherparepvec (T-VEC) injected (inj) into liver tumors in combination with pembrolizumab (pem)
Hecht, J. Randolph, Pless, Miklos, Cubillo, Antonio, Calvo, Aitana, Chon, Hong Jae, Liu, Chunxu, Snyder, Wendy, Chan, Emily, Chaney, Marya F., Chesney, Jason Alan, Prat, Aleix
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Relationship between inflammatory indexes and Khorana score (KS) with prognosis and survival in pancreatic ductal adenocarcinoma (PDAC)
Martín Lozano, Rocío, Jiménez Rodríguez, Roberto, Gonzalez Caraballo, Irene, Lobato Delgado, Bárbara, Gómez, María Palma, Muñoz, Marc Ariant Cañete, de Lucas, Mónica Benavente, López Jiménez, Carlos, Tirado Anula, Victoria, Morón García, Blanca, de Toro Carmena, María, Bringas Beranek, Marianela, Soto Alsar, Javier, Torres Pérez-Solero, Gabriela, Calvo, Aitana, Ortega, Laura, Soria, Jose Manuel, Garcia-Alfonso, Pilar, Martin, Miguel, Muñoz Martín, Andrés J.
Published in Journal of clinical oncology (01.02.2023)
Published in Journal of clinical oncology (01.02.2023)
Get full text
Journal Article
A phase 1b/2, multicenter, open-label trial to evaluate the safety of talimogene laherparepvec (T-VEC) injected into primary and metastatic liver tumors alone and in combination with pembrolizumab (pembro) (MASTERKEY-318)
Hecht, J. Randolph, Prat, Aleix, Pless, Miklos, Cubillo, Antonio, Calvo, Aitana, Raman, Steven, Chesney, Jason Alan, Liu, Chunxu, Chan, Emily
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Early safety from a phase 1, multicenter, open-label clinical trial of talimogene laherparepvec (T-VEC) injected into liver tumors
Hecht, J. Randolph, Pless, Miklos, Cubillo, Antonio, Calvo, Aitana, Raman, Steven, Liu, Chunxu, Chan, Emily, Chesney, Jason Alan, Prat, Aleix
Published in Journal of clinical oncology (01.02.2018)
Published in Journal of clinical oncology (01.02.2018)
Get full text
Journal Article
Phase I multicenter, open-label study to establish the maximum tolerated dose (MTD) of trifluridine/tipiracil (TAS-102) and oxaliplatin combination in patients (pts) with metastatic colorectal cancer (mCRC)
Hollebecque, Antoine, Calvo, Aitana, Andre, Thierry, Argiles, Guillem, Cervantes, Andres, Leger, Catherine, Valette, Aude, Amellal, Nadia, Fougeray, Ronan, Tabernero, Josep
Published in Journal of clinical oncology (01.02.2018)
Published in Journal of clinical oncology (01.02.2018)
Get full text
Journal Article
Trifluridine/tipiracil in combination with oxaliplatin and either bevacizumab or nivolumab: Results of the expansion part of a phase I study in patients with metastatic colorectal cancer
Bordonaro, Roberto, Calvo, Aitana, Auriemma, Alessandra, Hollebecque, Antoine, Rubovszky, Gabor, Saunders, Mark P., Papai, Zsuzsanna, Prager, Gerald W., Stein, Alexander, Andre, Thierry, Argiles, Guillem, Cubillo, Antonio, Dahan, Laetitia, Edeline, Julien, Leger, Catherine, Amellal, Nadia, Cattan, Valerie, Tabernero, Josep
Published in Journal of clinical oncology (01.02.2020)
Published in Journal of clinical oncology (01.02.2020)
Get full text
Journal Article
CheckMate 8KX: Phase 1/2 multitumor preliminary analyses of a subcutaneous formulation of nivolumab (± rHuPH20)
Lonardi, Sara, Lugowska, Iwona, Jackson, Christopher G. C. A., O'Donnell, Anne, Bahleda, Rastilav, Garrido, Marcelo, Latten-Jansen, Loes, Chacon, Matias, Yimer, Habte Aragaw, Camacho, Trixia, Konduri, Srivani, Aras, Urvi, Sanghavi, Kinjal, Vezina, Heather, Dolfi, Sonia, Alessi, Federica, Harvey, R Donald, Trigo, José, Calvo, Aitana
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Does HER2 status influence in the benefit of ramucirumab and paclitaxel as second line treatment of advanced gastro-esophageal adenocarcinoma? Data from the AGAMENON-SEOM registry
Valcarcel, Sena, Gallego, Javier, Jimenez-Fonseca, Paula, Diez, Marc, de Castro, Eva Martínez, Hernandez, Raquel, Arrazubi, Virginia, Custodio, Ana, Cano, Juana María, Montes, Ana Fernández, Macias, Ismael, Visa, Laura, Calvo, Aitana, Tocino, Rosario Vidal, Lago, Nieves Martínez, Limón, María Luisa, Granja, Mónica, Gil, Mireia, Pimentel, Paola, Macia-Rivas, Lola, Pérez, Carolina Hernández, Mangas, Montserrat, Carnicero, Alfonso Martín, Cerdà, Paula, Gonzalez, Lucía Gomez, Navalon, Francisco Garcia, Rambla, Mª Dolores Mediano, Richard, Marta Martin, Carmona-Bayonas, Alberto
Published in Journal of cancer research and clinical oncology (01.07.2023)
Published in Journal of cancer research and clinical oncology (01.07.2023)
Get full text
Journal Article
Retrospective analysis of clinical characteristics of mCRC patients receiving three or more lines of chemotherapy
Garcia Alfonso, Pilar, Martínez Delfrade, Íñigo, Soto Alsar, Javier, Bringas Beranek, Marianela, Gutiérrez Alonso, Natalia, Ortega, Laura, Torres, Gabriela, Muñoz Martín, Andres J., Blanco-Codesido, Montserrat, Calvo, Aitana, Martin, Miguel
Published in Journal of clinical oncology (01.02.2019)
Published in Journal of clinical oncology (01.02.2019)
Get full text
Journal Article
Single and Multiple Dose PK-PD Characterization for Carisoprodol. Part I: Pharmacokinetics, Metabolites, and 2C19 Phenotype Influence. Double-Blind, Placebo-Controlled Clinical Trial in Healthy Volunteers
Calvo, Aitana, Alonso, Saioa, Prieto, Esther, Ascaso-Del-Rio, Ana, Ortuño, Jordi, Fernandez, Nieves, Portolés, Antonio
Published in Journal of clinical medicine (06.02.2022)
Published in Journal of clinical medicine (06.02.2022)
Get full text
Journal Article